Related references
Note: Only part of the references are listed.Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5
Yoshifumi Takahata et al.
FASEB JOURNAL (2019)
Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation o transcription factor SOX4
Lixian Ding et al.
MOLECULAR CANCER (2019)
SOX4 regulates invasion of bladder cancer cells via repression of WNT5a
Josue D. Moran et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression
Hui Liu et al.
NEOPLASIA (2019)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in vitro and in vivo study
Guoyuan Li et al.
ACTA BIOMATERIALIA (2018)
Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells
Qing Du et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2018)
Osteoclast-secreted SLIT3 coordinates bone resorption and formation
Beom-Jun Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis
Xiaoyan Lei et al.
BIOSCIENCE REPORTS (2018)
Gloal transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis
Stephin J. Vervoort et al.
ELIFE (2018)
P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer
Shivani Sharma et al.
RNA (2017)
Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis
Manuel Scimeca et al.
CELL DEATH & DISEASE (2017)
LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4
Baoli Hu et al.
CANCER BIOLOGY & THERAPY (2017)
Management of severe osteoporosis
Paul D. Miller
EXPERT OPINION ON PHARMACOTHERAPY (2016)
SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma
Tae Mi Yoon et al.
BMC CANCER (2015)
A Polymorphism at the Translation Start Site of the Vitamin D Receptor Gene Is Associated with the Response to Anti-Osteoporotic Therapy in Postmenopausal Women from Southern Italy
Valeria Conti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Clinician's Guide to Prevention and Treatment of Osteoporosis
F. Cosman et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Genome-Wide Association Study Using Extreme Truncate Selection Identifies Novel Genes Affecting Bone Mineral Density and Fracture Risk
Emma L. Duncan et al.
PLOS GENETICS (2011)
SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro
Wonhee Hur et al.
CARCINOGENESIS (2010)
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice
Lise Sofie Haug Nissen-Meyer et al.
JOURNAL OF CELL SCIENCE (2007)
Prolonged glial expression of Sox4 in the CNS leads to architectural cerebellar defects and ataxia
Melanie Hoser et al.
JOURNAL OF NEUROSCIENCE (2007)
Genetic regulation of bone mass and susceptibility to osteoporosis
Stuart H. Ralston et al.
GENES & DEVELOPMENT (2006)
Epidemiology, etiology, and diagnosis of osteoporosis
NE Lane
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Share Paper
